<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Exozymes, Inc. — News on 6ix</title>
<link>https://6ix.com/company/exozymes-inc</link>
<description>Latest news and press releases for Exozymes, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 31 Mar 2026 20:20:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/exozymes-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683565a878dffbe2df0f02b5.webp</url>
<title>Exozymes, Inc.</title>
<link>https://6ix.com/company/exozymes-inc</link>
</image>
<item>
<title>eXoZymes Provides Fourth Quarter and Full Year 2025 Update</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-provides-fourth-quarter-and-full-year-2025-update</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-provides-fourth-quarter-and-full-year-2025-update</guid>
<pubDate>Tue, 31 Mar 2026 20:20:00 GMT</pubDate>
<description>Management to Host Conference Call Today at 5:30 PM Eastern LOS ANGELES, CA / ACCESS Newswire / March 31, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals ...</description>
</item>
<item>
<title>eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-to-host-fourth-quarter-and-full-year-2025-results-conference-call-on-tuesday-march-31-2026</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-to-host-fourth-quarter-and-full-year-2025-results-conference-call-on-tuesday-march-31-2026</guid>
<pubDate>Wed, 25 Mar 2026 20:10:00 GMT</pubDate>
<description>LOS ANGELES, CA / ACCESS Newswire / March 25, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines - announced the plan to host ...</description>
</item>
<item>
<title>Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability</title>
<link>https://6ix.com/company/exozymes-inc/news/successful-pilot-scale-run-with-cayman-chemical-validates-exozymes-technology-and-scalability</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/successful-pilot-scale-run-with-cayman-chemical-validates-exozymes-technology-and-scalability</guid>
<pubDate>Wed, 18 Mar 2026 13:10:00 GMT</pubDate>
<description>LOS ANGELES, CA / ACCESS Newswire / March 18, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines - announced an important validation ...</description>
</item>
<item>
<title>eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-cco-damien-perriman-to-present-a-nct-solution-at-next-weeks-mista-symposium-35</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-cco-damien-perriman-to-present-a-nct-solution-at-next-weeks-mista-symposium-35</guid>
<pubDate>Thu, 12 Mar 2026 20:15:00 GMT</pubDate>
<description>LOS ANGELES, CA / ACCESS Newswire / March 12, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines - announced that Perriman will ...</description>
</item>
<item>
<title>With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation</title>
<link>https://6ix.com/company/exozymes-inc/news/refreshed-brand-exozymes-sharpens-pharmaceutical-212000358</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/refreshed-brand-exozymes-sharpens-pharmaceutical-212000358</guid>
<pubDate>Tue, 10 Feb 2026 21:20:00 GMT</pubDate>
<description>LOS ANGELES, CALIFORNIA / ACCESS Newswire / February 10, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes transforming abundant feedstock into valuable nutraceuticals and new medicines - announced the launch ...</description>
</item>
<item>
<title>eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-advancing-commercial-readiness-profound-004500949</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-advancing-commercial-readiness-profound-004500949</guid>
<pubDate>Fri, 30 Jan 2026 00:45:00 GMT</pubDate>
<description>N-trans-caffeoyltyramine (NCT) is an interesting naturally occurring compound that has attracted scientific attention in exploratory studies related to lipid metabolism and energy utilization pathways. The production was executed by an external partner ...</description>
</item>
<item>
<title>eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-achieves-100-scale-nct-211000758</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-achieves-100-scale-nct-211000758</guid>
<pubDate>Thu, 11 Dec 2025 21:10:00 GMT</pubDate>
<description>LOS ANGELES, CALIFORNIA / ACCESS Newswire / December 11, 2025 /Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that can transform sustainable feedstock into nutraceuticals and new medicines - announced the successful ...</description>
</item>
<item>
<title>eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-provides-third-quarter-2025-213000449</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-provides-third-quarter-2025-213000449</guid>
<pubDate>Thu, 13 Nov 2025 21:30:00 GMT</pubDate>
<description>Management to host Q3 2025 update at 5:00PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 13, 2025 /Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that can transform sustainable feedstock ...</description>
</item>
<item>
<title>eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-announces-cell-free-biomanufacturing-211500634</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-announces-cell-free-biomanufacturing-211500634</guid>
<pubDate>Thu, 13 Nov 2025 21:15:00 GMT</pubDate>
<description>LOS ANGELES, CA / ACCESS Newswire / November 13, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that can transform sustainable feedstock into nutraceuticals and new medicines - announced that co-founder of ...</description>
</item>
<item>
<title>eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-host-third-quarter-2025-220000894</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-host-third-quarter-2025-220000894</guid>
<pubDate>Mon, 10 Nov 2025 22:00:00 GMT</pubDate>
<description>LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 10, 2025 /Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals ...</description>
</item>
<item>
<title>CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference</title>
<link>https://6ix.com/company/exozymes-inc/news/ceo-exozymes-ai-life-sciences-201000520</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/ceo-exozymes-ai-life-sciences-201000520</guid>
<pubDate>Thu, 30 Oct 2025 20:10:00 GMT</pubDate>
<description>LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 30, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals ...</description>
</item>
<item>
<title>CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference</title>
<link>https://6ix.com/company/exozymes-inc/news/ceo-exozymes-present-spartan-capital-214000520</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/ceo-exozymes-present-spartan-capital-214000520</guid>
<pubDate>Wed, 29 Oct 2025 21:40:00 GMT</pubDate>
<description>LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 29, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals ...</description>
</item>
<item>
<title>CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference</title>
<link>https://6ix.com/company/exozymes-inc/news/ceo-exozymes-present-thinkequitys-annual-205000559</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/ceo-exozymes-present-thinkequitys-annual-205000559</guid>
<pubDate>Thu, 23 Oct 2025 20:50:00 GMT</pubDate>
<description>LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 23, 2025 /Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals ...</description>
</item>
<item>
<title>eXoZymes Inc. Partners With B2i Digital to Spotlight the Cell-Free Next Generation of Biomanufacturing</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-inc-partners-b2i-digital-225837502</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-inc-partners-b2i-digital-225837502</guid>
<pubDate>Tue, 14 Oct 2025 22:58:37 GMT</pubDate>
<description>B2i Digital's Featured Company Profile Will Showcase eXoZymes' Cell-Free, AI-Guided Platform With Clear Milestones and Market Context eXoZymes Initially Targets Low Volume / High Value Natural Products - Like NCT - With a Potential for Pharmaceutical...</description>
</item>
<item>
<title>Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees</title>
<link>https://6ix.com/company/exozymes-inc/news/driving-cell-free-revolution-exozymes-201000767</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/driving-cell-free-revolution-exozymes-201000767</guid>
<pubDate>Tue, 30 Sep 2025 20:10:00 GMT</pubDate>
<description>LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 30, 2025 /Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals ...</description>
</item>
<item>
<title>eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-provides-second-quarter-2025-205000292</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-provides-second-quarter-2025-205000292</guid>
<pubDate>Tue, 12 Aug 2025 20:50:00 GMT</pubDate>
<description>Management to host earnings call at 5:00PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 12, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock ...</description>
</item>
<item>
<title>eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-host-second-quarter-2025-223500496</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-host-second-quarter-2025-223500496</guid>
<pubDate>Thu, 07 Aug 2025 22:35:00 GMT</pubDate>
<description>LOS ANGELES, CA / ACCESS Newswire / August 7, 2025 /Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - plans ...</description>
</item>
<item>
<title>eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-details-biomanufacturing-breakthrough-4-115700750</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-details-biomanufacturing-breakthrough-4-115700750</guid>
<pubDate>Tue, 29 Jul 2025 11:57:00 GMT</pubDate>
<description>Using eXoZymes' AI-driven exozymes platform, NCTx has demonstrated lab scale validation with 4 grams of NCT produced at a 96% yield and with a purity higher than 99%. NCT project went from concept to gram scale production in 5 months and at a fraction ...</description>
</item>
<item>
<title>eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-biomanufacturing-breakthrough-concept-gram-201000382</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-biomanufacturing-breakthrough-concept-gram-201000382</guid>
<pubDate>Tue, 22 Jul 2025 20:10:00 GMT</pubDate>
<description>N-trans-caffeoyltyramine (NCT) is a natural bioactive compound attracting considerable interest from researchers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial activity. Using eXoZymes' AI-driven platform, ...</description>
</item>
<item>
<title>eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing</title>
<link>https://6ix.com/company/exozymes-inc/news/exozymes-selected-core-industry-partner-201000424</link>
<guid isPermaLink="true">https://6ix.com/company/exozymes-inc/news/exozymes-selected-core-industry-partner-201000424</guid>
<pubDate>Thu, 26 Jun 2025 20:10:00 GMT</pubDate>
<description>MONROVIA, CA / ACCESS Newswire / June 26, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced ...</description>
</item>
</channel>
</rss>